Azizi Ghobad, Mayo Michelle L, Ogden Lorna L, Farrell Jessica, Piper Kele, Malchoff Carl
Wilmington Endocrinology, Wilmington, North Carolina, USA.
Thyroid Cytopathology Partners, Austin, Texas, USA.
VideoEndocrinology. 2023 Jul 13;10(2). doi: 10.1089/ve.2023.0016. eCollection 2023 Jun 1.
A 56-year-old woman was referred for thyroid nodules (TNs) found on a carotid ultrasonography (US). Her laboratories showed a normal thyroid stimulation hormone of 1.530 µIU/mL, normal thyroid hormone levels, and her thyroid antibodies were not elevated. Thyroid 2D US showed an isoechoic solid TN with regular margins measuring 12 × 8 × 10 mm (TR3) in the left thyroid lobe. 3D US demonstrated markedly irregular margins. The nodule volume was 0.52 cm. Based on current American Thyroid Association and American College of Radiology-Thyroid Imaging, Reporting and Data System (ACR-TIRADS) guidelines, her nodule size would not fit the criteria for fine needle aspiration biopsy (FNAB). However, because of the irregular margins seen on 3D US, FNAB was offered along with repeat US after 6 months. After considering her options, she requested FNAB. She underwent effective US guided FNAB of the left TN and the cytopathology report indicated follicular neoplasm Bethesda category IV. Subsequently, she had follow-up US guided FNAB for molecular testing with the Afirma's gene sequencing classifier (GSC). The report showed GSC suspicious with an NRAS mutation, indicating a 50% malignancy risk. She elected to have left hemithyroidectomy. The final surgical pathology report demonstrated a 12-mm follicular carcinoma.
In our thyroid clinic, we utilize conventional 2D US and 3D US to evaluate TN for possible FNAB. Laboratory measurements were performed at Labcorp. Informed consent was given by the patient. The 3D image acquisition follows 2D US examination. The first step in 3D US image acquisition is identifying the target nodule utilizing 2D US. Next, the 3D sweep of the target nodule produces a 3D volume data set and observation of 3D-rendered images generated simultaneously from longitudinal, transverse, and coronal views. A 2D US image displays a TN only on one plane in two dimensions, longitudinal or transverse. The saved 3D volume data set can be viewed and manipulated later. We can reconstruct new images from different angles after the study is completed. The 3D image acquisition direction (front to back versus up to down) will create a different display image and volume slice. The examiner can choose the direction of 3D acquisition before 3D sweep. A 2D US image or machine lacks these qualities.
This case illuminates recent advances in 3D US imaging and demonstrates that this technology may enhance the value of 2D US in diagnosing malignancy. This technology allows the user to create sequential cross-sectional images through the target nodule. The addition of coronal view to the existing 2D US has been an important contributing factor. Several recent publications have reported that 3D US can improve nodule selection criteria for FNAB. Our clinic has routinely utilized 3D US technology for the past 4 years. We have learned that this new technology can delineate TN borders more clearly. It not only enhances the observation of structures within but also those attached to the thyroid gland. The target nodule can be rotated and viewed from different angles. The margin irregularities of TNs can be viewed with 3D US in small and large nodules equally. We have found that the 3D US shows the irregular margins of malignant TNs to be more pronounced when compared with high-end 2D US systems. In our experience, the vast majority of benign TNs have regular margins on 3D US. Finally, the 3D volume measurement may provide additional information about the size of TNs for longitudinal follow-up of nodules with benign FNAB. The limitations or challenges of using 3D US in general practice include the cost of the ultrasound machine, lack of reimbursement, and the provider's learning curve. Adding 3D/4D technology to current 2D US does provide more detailed information; however, it requires additional time to complete a thyroid US study. 3D US technology might be more suitable for thyroid clinics or endocrine practices with high patient volumes.
We conclude that 3D US can enhance observation of TN margin irregularities and potentially improve nodule selection for FNAB.
No competing financial interests exist.
Runtime of video: 2 hrs 25 mins 12 secs.
一名56岁女性因颈动脉超声检查发现甲状腺结节(TNs)前来就诊。她的实验室检查显示促甲状腺激素正常,为1.530 µIU/mL,甲状腺激素水平正常,甲状腺抗体未升高。甲状腺二维超声显示左叶甲状腺有一个等回声实性TN,边界规则,大小为12 × 8 × 10 mm(TR3)。三维超声显示边界明显不规则。结节体积为0.52 cm。根据美国甲状腺协会和美国放射学会甲状腺影像报告和数据系统(ACR-TIRADS)现行指南,她的结节大小不符合细针穿刺活检(FNAB)标准。然而,由于三维超声显示边界不规则,建议进行FNAB并在6个月后复查超声。在考虑了各种选择后,她要求进行FNAB。她接受了有效的超声引导下左TN细针穿刺活检,细胞病理学报告显示为贝塞斯达IV类滤泡性肿瘤。随后,她接受了超声引导下的后续细针穿刺活检以进行分子检测,使用的是Afirma基因测序分类器(GSC)。报告显示GSC可疑,存在NRAS突变,提示恶性风险为50%。她选择进行左半甲状腺切除术。最终手术病理报告显示为12毫米滤泡癌。
在我们的甲状腺诊所,我们使用传统二维超声和三维超声评估TNs以确定是否可能进行FNAB。实验室检测在Labcorp进行。患者签署了知情同意书。三维图像采集在二维超声检查之后进行。三维超声图像采集的第一步是利用二维超声识别目标结节。接下来,对目标结节进行三维扫描生成三维体积数据集,并观察同时从纵向、横向和冠状视图生成的三维渲染图像。二维超声图像仅在纵向或横向的一个平面上显示TN。保存的三维体积数据集稍后可以查看和操作。研究完成后,我们可以从不同角度重建新图像。三维图像采集方向(从前到后与从上到下)会产生不同的显示图像和体积切片。检查者可以在三维扫描之前选择三维采集方向。二维超声图像或机器则不具备这些特性。
本病例阐明了三维超声成像的最新进展,并表明该技术可能会提高二维超声在诊断恶性肿瘤方面的价值。该技术允许用户通过目标结节创建连续的横截面图像。在现有的二维超声基础上增加冠状视图是一个重要的促成因素。最近的几篇出版物报道,三维超声可以改善FNAB的结节选择标准。在过去4年里,我们诊所一直常规使用三维超声技术。我们了解到这项新技术可以更清晰地勾勒TN的边界。它不仅增强了对内部结构的观察,还增强了对附着于甲状腺结构的观察。目标结节可以旋转并从不同角度查看。无论大小结节,三维超声都能观察到TN的边界不规则情况。我们发现,与高端二维超声系统相比,三维超声显示恶性TN的边界不规则更为明显。根据我们的经验,绝大多数良性TN在三维超声上边界规则。最后,三维体积测量可能为良性FNAB结节的纵向随访提供有关TN大小的额外信息。在一般实践中使用三维超声的局限性或挑战包括超声机器的成本、缺乏报销以及提供者的学习曲线。在当前二维超声基础上增加三维/四维技术确实能提供更详细的信息;然而,完成甲状腺超声检查需要额外的时间。三维超声技术可能更适合患者量大的甲状腺诊所或内分泌科。
我们得出结论,三维超声可以增强对TN边界不规则情况的观察,并可能改善FNAB的结节选择。
不存在相互竞争的财务利益。
视频时长:2小时25分12秒。